Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monocyte chemoattractant protein 3 (MCP‑3), also known as CCL7, is a chemokine belonging to the CC subfamily. It acts as a potent chemoattractant for multiple leukocyte types, including monocytes, eosinophils, basophils, dendritic cells, neutrophils, NK cells, and activated T lymphocytes. It plays important roles in normal homeostasis as well as pathologies such as cancer, autoimmune diseases, chronic inflammation, and infection.
Recruitment of leukocytes via CCR1, CCR2, and CCR3 receptor activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monocyte chemoattractant protein 3 (MCP‑3/CCL7).